These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 10995988)
1. Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients. Włodarczyk Z; Oko A; Glyda M; Karczewski M; Idasiak-Piechocka I; Czekalski S Transplant Proc; 2000 Sep; 32(6):1382-3. PubMed ID: 10995988 [No Abstract] [Full Text] [Related]
2. A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft. Noël C; Hazzan M; Coppin MC; Codaccioni MX; Pruvot FR; Labalette M; Lelièvre G Clin Transplant; 1997 Jun; 11(3):169-73. PubMed ID: 9193837 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of delayed kidney graft function: role of endothelin-1, thromboxane B2, and leukotriene B4. Schilling M; Holzinger F; Friess H; Seiler C; Büchler MW Transplant Proc; 1996 Feb; 28(1):304-5. PubMed ID: 8644233 [No Abstract] [Full Text] [Related]
4. Eicosanoids and delayed graft function in human renal transplantation. Norio K; Saareks V; Vapaatalo H; Mäkisalo H; Pere P; Lindgren L Transplant Proc; 2001 Jun; 33(4):2530-1. PubMed ID: 11406239 [No Abstract] [Full Text] [Related]
5. Improvement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trial. Noel C; Hazzan M; Labalette M; Coppin MC; Jude B; Dessaint JP; Lelievre G Transplantation; 1998 Feb; 65(3):385-9. PubMed ID: 9484756 [TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281 [TBL] [Abstract][Full Text] [Related]
7. Effects of misoprostol on renal function and plasma endothelin-1 levels during early postoperative stage of living donor renal transplant recipients. Kim HJ; Kwak JY Transplant Proc; 1996 Jun; 28(3):1207-9. PubMed ID: 8658628 [No Abstract] [Full Text] [Related]
8. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. Baskett A; Barton MH; Norton N; Anders B; Moore JN Am J Vet Res; 1997 Nov; 58(11):1291-9. PubMed ID: 9361895 [TBL] [Abstract][Full Text] [Related]
9. Suppression of OKT3-induced tumor necrosis factor alpha formation by pentoxifylline in renal transplant recipients. Leimenstoll G; Zabel P; Schroeder P; Schlaak M; Niedermayer W Transplant Proc; 1993 Feb; 25(1 Pt 1):561-3. PubMed ID: 8438414 [No Abstract] [Full Text] [Related]
10. Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms. Bahrmann P; Hengst UM; Richartz BM; Figulla HR Eur J Heart Fail; 2004 Mar; 6(2):195-201. PubMed ID: 14984727 [TBL] [Abstract][Full Text] [Related]
11. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. Barton MH; Moore JN; Norton N Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896 [TBL] [Abstract][Full Text] [Related]
12. No evidence for use of pentoxifylline in acute Kawasaki disease. Nash MC; Wade AM Eur J Pediatr; 1996 Mar; 155(3):258. PubMed ID: 8929744 [No Abstract] [Full Text] [Related]
13. Influence of delayed graft function in renal transplants from cadaveric or non-heart-beating donors. White SA; Jain S; Absalom H; Murphy G; Williams ST; Knight A; Zickerman AM; Nicholson ML Transplant Proc; 2000 Feb; 32(1):189. PubMed ID: 10701018 [No Abstract] [Full Text] [Related]
14. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital. Vathsala A; Woo KT Clin Transpl; 1999; ():189-97. PubMed ID: 11038637 [TBL] [Abstract][Full Text] [Related]
15. Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation. Carrier M; Pelletier GB; White M; Bois D; Pelletier LC J Heart Lung Transplant; 1996 Dec; 15(12):1179-83. PubMed ID: 8981202 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Koning OH; Ploeg RJ; van Bockel JH; Groenewegen M; van der Woude FJ; Persijn GG; Hermans J Transplantation; 1997 Jun; 63(11):1620-8. PubMed ID: 9197357 [TBL] [Abstract][Full Text] [Related]
17. C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy. Sliwa K; Woodiwiss A; Libhaber E; Zhanje F; Libhaber C; Motara R; Essop R Eur J Heart Fail; 2004 Oct; 6(6):731-4. PubMed ID: 15542408 [No Abstract] [Full Text] [Related]
18. Pentoxifylline: brief review and rationale for its possible use in the treatment of autism. Gupta S; Rimland B; Shilling PD J Child Neurol; 1996 Nov; 11(6):501-4. PubMed ID: 9120235 [No Abstract] [Full Text] [Related]
19. Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data. Bresnahan BA; McBride MA; Cherikh WS; Hariharan S Transplantation; 2001 Jul; 72(2):256-61. PubMed ID: 11477349 [TBL] [Abstract][Full Text] [Related]
20. A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy. Gupta SK; Dubé MP; Stein JH; Clauss MA; Liu Z AIDS; 2016 Aug; 30(13):2139-42. PubMed ID: 27465282 [No Abstract] [Full Text] [Related] [Next] [New Search]